A
NYSEAGILENT TECHNOLOGIES, INC.
Health Care, Life Sciences Tools & Services
$145.97
close 7 Aug 2026
+27.90%
52-week change
$41.20B
market cap
$108.35
$160.27
52-week range
| Line item | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income | ||||||||||||||||||||
| Revenue | $7.23B | $6.95B | $6.51B | $6.83B | $6.85B | $6.32B | $5.34B | $5.16B | $4.91B | $4.47B | $4.20B | $4.04B | $4.05B | $3.89B | $6.86B | $6.62B | $5.44B | $4.48B | $5.77B | $5.42B |
| Cost of revenue | $3.42B | $3.31B | $2.98B | $3.37B | $3.13B | $2.91B | $2.50B | $2.36B | $2.23B | $2.07B | $2.01B | $2.00B | $2.07B | $1.99B | $3.25B | $3.09B | $2.51B | $2.19B | $2.58B | $2.45B |
| Gross profit | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| R&D | $473.00M | $455.00M | $479.00M | $481.00M | $467.00M | $441.00M | $495.00M | $404.00M | $387.00M | $341.00M | $329.00M | $330.00M | $358.00M | $337.00M | $668.00M | $649.00M | $612.00M | $642.00M | $704.00M | $685.00M |
| SG&A | $1.79B | $1.71B | $1.57B | $1.63B | $1.64B | $1.62B | $1.50B | $1.46B | $1.39B | $1.25B | $1.25B | $1.19B | $1.20B | $1.18B | $1.82B | $1.81B | $1.75B | $1.60B | $1.70B | $1.70B |
| Operating income | $1.56B | $1.48B | $1.49B | $1.35B | $1.62B | $1.35B | $846.00M | $941.00M | $904.00M | $807.00M | $615.00M | $522.00M | $419.00M | $386.00M | $1.12B | $1.07B | $566.00M | $47.00M | $795.00M | $584.00M |
| Interest expense | $105.00M | $112.00M | $96.00M | $95.00M | $84.00M | $81.00M | $78.00M | $74.00M | $75.00M | $79.00M | $72.00M | $66.00M | $110.00M | $107.00M | $101.00M | $86.00M | $96.00M | $88.00M | $123.00M | $91.00M |
| Tax expense | $166.00M | $132.00M | $232.00M | $99.00M | $250.00M | $150.00M | $123.00M | -$152.00M | $630.00M | $119.00M | $82.00M | $42.00M | -$3.00M | $68.00M | -$110.00M | $20.00M | $8.00M | $38.00M | $122.00M | $32.00M |
| Net income | $1.41B | $1.30B | $1.29B | $1.24B | $1.25B | $1.21B | $719.00M | $1.07B | $316.00M | $684.00M | $462.00M | $401.00M | $549.00M | $734.00M | $1.15B | $1.01B | $684.00M | -$31.00M | $693.00M | $638.00M |
| Diluted EPS | $4.98 | $4.57 | $4.43 | $4.19 | $4.18 | $3.94 | $2.30 | $3.37 | $0.9700 | $2.10 | $1.40 | $1.20 | $1.62 | $2.13 | $3.27 | $2.85 | $1.94 | -$0.0900 | $1.87 | $1.57 |
| Gross margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating margin | 21.50% | 21.29% | 22.86% | 19.76% | 23.63% | 21.32% | 15.85% | 18.23% | 18.40% | 18.05% | 14.64% | 12.93% | 10.35% | 9.91% | 16.32% | 16.19% | 10.40% | 1.05% | 13.77% | 10.77% |
| Net margin | 19.55% | 18.75% | 19.80% | 18.15% | 18.31% | 19.15% | 13.47% | 20.74% | 6.43% | 15.30% | 10.99% | 9.93% | 13.56% | 18.85% | 16.81% | 15.30% | 12.56% | -0.69% | 12.00% | 11.77% |
filed 1 Jun 2026